Allecra Therapeutics receives FDA approval for treatment targeting severe UTIs

Allecra Therapeutics, a biopharma company developing novel therapies to combat antibiotic resistance, has received FDA approval for its treatment tackling ‘complicated’ urinary tract infections (UTIs).

Related Keywords

Patrick Velicitat ,Omar Lahlou ,Iain Buchanan ,Committee For Medicinal Products Human ,European Medicines Agency ,Us Congress ,Generating Antibiotic Incentives Now Act ,Qualified Infectious Disease Products ,Medicinal Products ,Human Use ,Bio Developments ,Markets Amp Regulations ,Pipelines ,Emerging Markets ,Ti ,Urinary Tract Infection ,Fda ,Food And Drug Administration ,Clinical Trial ,